Inventor · disambiguated record
Namrata Patil
Also filed as: PATIL NAMRATA · PATIL NAMRATA SRIVASTAVA
3 granted patents·9 pending applications·5 citations·filing 2014–2025
60Inventor score
Top patents by PatentIndex Score
12 records- 0184US10172937B2Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·5 cites·32 claims
- 0275US12465636B2Method of making afucosylated anti-FGFR2IIIB antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 0369US2025269016A1Afucosylated Anti-FGFR2IIIB AntibodiesFIVE PRIME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0466US11235059B2Afucosylated anti-FGFR2IIIB antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·0 cites·59 claims
- 0559US2025285457A1Machine learning enabled histological analysisGENENTECH INC·Filed 2025·Application pending·0 cites
- 0659US2015050273A1Afucosylated anti-fgfr2iiib antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 0756US2025295766A1Prognostic and therapeutic methods for cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 0855US2022324981A1Dosing for treatment with anti-tigit and anti-pd-l1 antagonist antibodiesGENENTECH INC·Filed 2022·Application pending·0 cites
- 0949US2023392210A1Methods and compositions for cancer immunotherapyGENENTECH INC·Filed 2022·Application pending·0 cites
- 1048US2022098318A1Dosing for treatment with anti-tigit and anti-cd20 or anti-cd38 antibodiesGENENTECH INC·Filed 2021·Application pending·0 cites
- 1145US2021292851A1Method of monitoring effectiveness of immunotherapy of cancer patientsROCHE SEQUENCING SOLUTIONS INC·Filed 2019·Application pending·0 cites
- 1242US2020399376A1Dosing for treatment with anti-tigit and anti-pd-l1 antagonist antibodiesGENENTECH INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →